poisar

Stocks · News reference

GSK Canada Receives Approval For Shingrix Zoster Vaccine In Prefilled Syringe

BenzingaJul 24, 2026, 3:30 PMBenzinga Newsdesk

GSK Canada today announced the approval of Shingrix (GSK's Recombinant Zoster Vaccine or RZV) in a prefilled syringe. This new presentation removes the need to reconstitute separate vials prior to administration,

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Jul 24, 2026, 3:30 PM
Checked
Jul 24, 2026, 3:30 PM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading